Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Lingor

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
Journal of Neurochemistry|March 30, 2011
Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivoLars Tönges, Thomas Ostendorf, Fabienne Lamballe, et al.
Journal of Medicinal Chemistry|June 9, 2006
Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanismNicolas Pietrancosta, Anice Moumen, Rosanna Dono, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 12, 2018
Motor Unit Number Index (MUNIX) of hand muscles is a disease biomarker for adult spinal muscular atrophyRené Günther, Christoph Neuwirth, Jan Christoph Koch, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 3, 2026
Effects of fasudil on disease spreading in ALS - A MUNIX-based post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
Journal of Neurochemistry|February 2, 2018
Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's diseaseFabian Maass, Bernhard Michalke, Andreas Leha, et al.
Brain : a Journal of Neurology|September 2, 2008
BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activityVéronique Planchamp, Christina Bermel, Lars Tönges, et al.
Molecular Neurobiology|August 4, 2025
An Exploratory Analysis of Differential Tear Fluid miRNAs in Patients with Parkinson's Disease and Atypical Parkinsonian SyndromesAntonia F Demleitner, Lucas Caldi Gomes, Lara Wenz, et al.
Journal of Neurochemistry|December 20, 2020
Rho-kinase inhibition by fasudil modulates pre-synaptic vesicle dynamicsKim Ann Saal, Carmina Warth Pérez Arias, Anna-Elisa Roser, et al.
Parkinsonism & Related Disorders|March 17, 2019
Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot studyMatthias Boerger, Sebastian Funke, Andreas Leha, et al.
Frontiers in Aging Neuroscience|February 29, 2024
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD)Andreas W Wolff, Helen Bidner, Yvonne Remane, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Journal of Neurochemistry|March 30, 2011
Hepatocyte growth factor protects retinal ganglion cells by increasing neuronal survival and axonal regeneration in vitro and in vivoLars Tönges, Thomas Ostendorf, Fabienne Lamballe, et al.
Journal of Medicinal Chemistry|June 9, 2006
Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanismNicolas Pietrancosta, Anice Moumen, Rosanna Dono, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 12, 2018
Motor Unit Number Index (MUNIX) of hand muscles is a disease biomarker for adult spinal muscular atrophyRené Günther, Christoph Neuwirth, Jan Christoph Koch, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 3, 2026
Effects of fasudil on disease spreading in ALS - A MUNIX-based post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
Journal of Neurochemistry|February 2, 2018
Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's diseaseFabian Maass, Bernhard Michalke, Andreas Leha, et al.
Brain : a Journal of Neurology|September 2, 2008
BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activityVéronique Planchamp, Christina Bermel, Lars Tönges, et al.
Molecular Neurobiology|August 4, 2025
An Exploratory Analysis of Differential Tear Fluid miRNAs in Patients with Parkinson's Disease and Atypical Parkinsonian SyndromesAntonia F Demleitner, Lucas Caldi Gomes, Lara Wenz, et al.
Journal of Neurochemistry|December 20, 2020
Rho-kinase inhibition by fasudil modulates pre-synaptic vesicle dynamicsKim Ann Saal, Carmina Warth Pérez Arias, Anna-Elisa Roser, et al.
Parkinsonism & Related Disorders|March 17, 2019
Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot studyMatthias Boerger, Sebastian Funke, Andreas Leha, et al.
Frontiers in Aging Neuroscience|February 29, 2024
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD)Andreas W Wolff, Helen Bidner, Yvonne Remane, et al.
Pageof 18